Nearly 10% of Patients Develop Breast Cancer After Prior Benign Breast Disease

Share this content:
A substantial proportion of all breast cancers develop in patients with prior benign breast disease.
A substantial proportion of all breast cancers develop in patients with prior benign breast disease.

A substantial proportion of all breast cancers develop in patients with prior benign breast disease, a new study published online ahead of print in the journal Cancer has shown.1

Although women with benign breast disease have an increased risk for developing breast cancer, there is limited evidence regarding the clinicopathologic features of breast cancers in these patients. Therefore, a team of researchers led by Amy C. Degnim, MD, of the Division of Cancer Biology at Mayo Clinic in Jacksonville, FL, sought to characterize breast cancers developing in a large cohort of women with benign breast disease.

Researchers analyzed data from a cohort of 13,485 women who underwent breast biopsy for mammographic or palpable concerns between 1967 and 2011.

Results showed that with a median follow-up of 15.8 years, 1,273 women developed breast cancer. Of those, 81% were invasive, of which 61% were ductal, 13% were mixed/lobular, and 14% were lobular.

Researchers found that approximately two-thirds of all breast cancer cases in the cohort were intermediate or high grade, and 29% were lymph node positive.

RELATED: Everolimus Efficacy Independent of Genetic Alterations in EGFR2-negative Breast Cancer

The study also demonstrated that women with atypical hyperplasia had a higher frequency of estrogen receptor-positive breast cancer compared with those with proliferative disease without atypia or nonproliferative disease (P = .02).

“Prevention therapy should be strongly encouraged in higher-risk women with [benign breast disease],” the authors concluded.

Editor's Note: Article was updated on November 2, 2015.

Reference

  1. Visscher DW, Frost MH, Hartmann LC, et al. Clinicopathologic features of breast cancers that develop in women with previous benign breast disease [published online ahead of print October 29, 2015]. Cancer. doi: 10.1002/cncr.29766.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters